董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Katharyn Field | 女 | Executive Director and Interim Chief Executive Officer | 41 | 9.60万美元 | 未持股 | 2025-09-18 |
| Katharyn Field | 女 | Executive Director and Interim Chief Executive Officer | 41 | 未披露 | 未持股 | 2025-09-18 |
| Usama Chaudhry | 男 | Independent Director | 34 | 未披露 | 未持股 | 2025-09-18 |
| Christopher Cooper | 男 | Director and President of First Towers | 55 | 2.00万美元 | 未持股 | 2025-09-18 |
| David Jenkins | 男 | Independent Director | 43 | 9.60万美元 | 未持股 | 2025-09-18 |
| Jatinder Dhaliwal | 男 | Independent Director | 35 | 9.60万美元 | 未持股 | 2025-09-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Katharyn Field | 女 | Executive Director and Interim Chief Executive Officer | 41 | 9.60万美元 | 未持股 | 2025-09-18 |
| Katharyn Field | 女 | Executive Director and Interim Chief Executive Officer | 41 | 未披露 | 未持股 | 2025-09-18 |
| Gurcharn Deol | 男 | Chief Financial Officer | 56 | 2.76万美元 | 未持股 | 2025-09-18 |
| Edgar Contreras | 男 | Country Manager of First Towers | 52 | 未披露 | 未持股 | 2025-09-18 |
| Christopher Cooper | 男 | Director and President of First Towers | 55 | 2.00万美元 | 未持股 | 2025-09-18 |
| Francisco Juarez | 男 | Chief Operating Officer of First Towers and VP | 47 | 未披露 | 未持股 | 2025-09-18 |
董事简历
中英对照 | 中文 | 英文- Katharyn Field
-
Katharyn Field，自2024年10月起担任Logprostyle Inc.独立董事。在为Logprostyle Inc.公司服务期间，Field女士还曾在Virpax Pharmaceuticals Inc.担任独立董事和审计委员会成员，该公司是一家专业制药公司，专注于凭借其旗舰产品利用专有脂质体封装（纳斯达克：VRPX）开创先进的医疗保健解决方案，自2024年7月起，在iSpecimen Inc.担任独立董事和审计委员会成员。TERM4 Inc.是一家提供技术的公司，该公司将需要人类生物流体、组织和活细胞进行研究的生命科学研究人员与全球医疗保健提供机构（TERM0纳斯达克：ISPC）中可用的生物标本连接起来，自2024年9月以来，自2022年7月起在Halo Collective Inc.担任首席执行官和董事会主席，该公司是一家在加拿大和美国从事大麻和大麻提取物的种植、制造、运输和分销的公司（OTC：HCANF），自2022年6月起在Akanda Corporation担任临时首席执行官和执行董事，该公司是一家为药用Logprostyle Inc. e worldwide（纳斯达克：AKAN）从事大麻制品种植、制造和分销的公司。在加入Logprostyle Inc.公司之前，Field女士曾于2013年1月至2017年1月在美国园艺种植商Costa Farms担任董事，于2017年1月至2018年1月担任顾问，于2018年1月至2019年3月在MariMed Inc.担任高级副总裁，该公司在美国和国际上从事药用和娱乐大麻的种植、生产和分配（OTC：MRMD），并于2019年4月至2020年2月担任Halo Collective Inc.的首席战略官，并于2020年2月至2022年7月担任其总裁。Field女士于2005年获得斯坦福大学公共政策学士学位，并于2011年获得哥伦比亚大学工商管理硕士学位。
Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field’s resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison’s office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University. - Katharyn Field，自2024年10月起担任Logprostyle Inc.独立董事。在为Logprostyle Inc.公司服务期间，Field女士还曾在Virpax Pharmaceuticals Inc.担任独立董事和审计委员会成员，该公司是一家专业制药公司，专注于凭借其旗舰产品利用专有脂质体封装（纳斯达克：VRPX）开创先进的医疗保健解决方案，自2024年7月起，在iSpecimen Inc.担任独立董事和审计委员会成员。TERM4 Inc.是一家提供技术的公司，该公司将需要人类生物流体、组织和活细胞进行研究的生命科学研究人员与全球医疗保健提供机构（TERM0纳斯达克：ISPC）中可用的生物标本连接起来，自2024年9月以来，自2022年7月起在Halo Collective Inc.担任首席执行官和董事会主席，该公司是一家在加拿大和美国从事大麻和大麻提取物的种植、制造、运输和分销的公司（OTC：HCANF），自2022年6月起在Akanda Corporation担任临时首席执行官和执行董事，该公司是一家为药用Logprostyle Inc. e worldwide（纳斯达克：AKAN）从事大麻制品种植、制造和分销的公司。在加入Logprostyle Inc.公司之前，Field女士曾于2013年1月至2017年1月在美国园艺种植商Costa Farms担任董事，于2017年1月至2018年1月担任顾问，于2018年1月至2019年3月在MariMed Inc.担任高级副总裁，该公司在美国和国际上从事药用和娱乐大麻的种植、生产和分配（OTC：MRMD），并于2019年4月至2020年2月担任Halo Collective Inc.的首席战略官，并于2020年2月至2022年7月担任其总裁。Field女士于2005年获得斯坦福大学公共政策学士学位，并于2011年获得哥伦比亚大学工商管理硕士学位。
- Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field’s resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison’s office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University.
- Katharyn Field
-
Katharyn Field自2022年7月起担任执行董事，自2023年2月起担任临时首席执行官。菲尔德女士目前也是Halo的首席执行官兼董事长，她自2022年6月以来一直担任该职位。Field女士目前是LogProstyle的董事，自2025年2月起担任iSpecimen公司的总裁，这两家公司都是上市公司。从2020年2月到2022年6月，菲尔德女士担任大麻公司Halo Collective Inc.的总裁，从2019年4月到2020年2月，她担任该公司的首席战略官。菲尔德女士的履历包括2005年10月至2009年5月在布鲁金斯学会任职，2011年9月至2013年3月在贝恩公司任职。2014年，她进入大麻产业，领导了佛罗里达州五家拥有州许可证的原始垂直整合公司之一的采购、建设和销售。随后，Field女士经营着一家专注于大麻的战略咨询业务，并于2018年5月至2019年1月在MariMed工作，担任企业发展执行副总裁。菲尔德女士还在George W. BH执政期间完成了在白锄公共联络办公室的实习。菲尔德女士拥有哥伦比亚BINCE学校的MBA学位和斯坦福大学的荣誉学士学位。
Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field's resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison's office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University. - Katharyn Field自2022年7月起担任执行董事，自2023年2月起担任临时首席执行官。菲尔德女士目前也是Halo的首席执行官兼董事长，她自2022年6月以来一直担任该职位。Field女士目前是LogProstyle的董事，自2025年2月起担任iSpecimen公司的总裁，这两家公司都是上市公司。从2020年2月到2022年6月，菲尔德女士担任大麻公司Halo Collective Inc.的总裁，从2019年4月到2020年2月，她担任该公司的首席战略官。菲尔德女士的履历包括2005年10月至2009年5月在布鲁金斯学会任职，2011年9月至2013年3月在贝恩公司任职。2014年，她进入大麻产业，领导了佛罗里达州五家拥有州许可证的原始垂直整合公司之一的采购、建设和销售。随后，Field女士经营着一家专注于大麻的战略咨询业务，并于2018年5月至2019年1月在MariMed工作，担任企业发展执行副总裁。菲尔德女士还在George W. BH执政期间完成了在白锄公共联络办公室的实习。菲尔德女士拥有哥伦比亚BINCE学校的MBA学位和斯坦福大学的荣誉学士学位。
- Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field's resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison's office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University.
- Usama Chaudhry
-
自2025年以来，ama Chaudhry一直担任董事之一。他是一位经验丰富的高管，在企业管理方面拥有广泛的专业知识，目前在多个上市公司董事会任职。他自2016年起担任Chaudhry U Consulting Inc.的负责人，自2019年6月起担任Peakbirch Logic的首席财务官和董事，自2020年2月起担任EGF Theramed Health Corp.（OTCPink：EVAHF）的首席财务官和董事，自2020年1月起担任Global Health Clinics Ltd.（OTCPink：LRSNF）的首席财务官。他于2024年11月至2025年4月担任Virpax Pharmaceuticals, Inc.（OTCPink：VRPX）的首席财务官。他还是Binovi Technologies Corp.（OTC Expert Market：BNVIF）和Vantex Resces Ltd.（OTCPink：VANTF）的董事。他的专业领域包括企业发展、投资者关系、财务报告和公司治理。他擅长将战略目标与严格的成本控制措施保持一致，以提高组织绩效。Chaudhry先生获得了北不列颠哥伦比亚大学的商业学士学位，主修会计学。
Usama Chaudhry has served as one of directors since 2025. He is a seasoned executive with a broad expertise in corporate management, currently serving on several public company boards. He is the principal of Chaudhry U Consulting Inc., since 2016, and he has been the CFO and a director of Peakbirch Logic since June 2019, of EGF Theramed Health Corp. (OTCPink: EVAHF) since February 2020 and of Global Health Clinics Ltd. (OTCPink: LRSNF) since January 2020. He was the CFO of Virpax Pharmaceuticals, Inc. (OTCPink:VRPX) from November 2024 to April 2025. He is also a director of Binovi Technologies Corp. (OTC Expert Market: BNVIF) and Vantex Resces Ltd. (OTCPink: VANTF). His specialty areas encompass corporate development, investor relations, financial reporting, and corporate governance. He excels at aligning strategic objectives with rigoro cost control measures to enhance organizational performance. Mr. Chaudhry earned his Bachelor of Commerce degree, majoring in accounting, from the University of Northern British Columbia. - 自2025年以来，ama Chaudhry一直担任董事之一。他是一位经验丰富的高管，在企业管理方面拥有广泛的专业知识，目前在多个上市公司董事会任职。他自2016年起担任Chaudhry U Consulting Inc.的负责人，自2019年6月起担任Peakbirch Logic的首席财务官和董事，自2020年2月起担任EGF Theramed Health Corp.（OTCPink：EVAHF）的首席财务官和董事，自2020年1月起担任Global Health Clinics Ltd.（OTCPink：LRSNF）的首席财务官。他于2024年11月至2025年4月担任Virpax Pharmaceuticals, Inc.（OTCPink：VRPX）的首席财务官。他还是Binovi Technologies Corp.（OTC Expert Market：BNVIF）和Vantex Resces Ltd.（OTCPink：VANTF）的董事。他的专业领域包括企业发展、投资者关系、财务报告和公司治理。他擅长将战略目标与严格的成本控制措施保持一致，以提高组织绩效。Chaudhry先生获得了北不列颠哥伦比亚大学的商业学士学位，主修会计学。
- Usama Chaudhry has served as one of directors since 2025. He is a seasoned executive with a broad expertise in corporate management, currently serving on several public company boards. He is the principal of Chaudhry U Consulting Inc., since 2016, and he has been the CFO and a director of Peakbirch Logic since June 2019, of EGF Theramed Health Corp. (OTCPink: EVAHF) since February 2020 and of Global Health Clinics Ltd. (OTCPink: LRSNF) since January 2020. He was the CFO of Virpax Pharmaceuticals, Inc. (OTCPink:VRPX) from November 2024 to April 2025. He is also a director of Binovi Technologies Corp. (OTC Expert Market: BNVIF) and Vantex Resces Ltd. (OTCPink: VANTF). His specialty areas encompass corporate development, investor relations, financial reporting, and corporate governance. He excels at aligning strategic objectives with rigoro cost control measures to enhance organizational performance. Mr. Chaudhry earned his Bachelor of Commerce degree, majoring in accounting, from the University of Northern British Columbia.
- Christopher Cooper
-
克里斯托弗.库珀自2024年4月起担任董事之一。Cooper先生在私营和公共部门的企业发展、高级管理层、财务和运营的各个方面拥有超过20年的BINCE经验。他的经验包括领导增长战略、财务报告、季度和年度预算、监督公司管理，同时实现公司目标和保持内部成本控制。Cooper先生目前的主要职业是BINCE顾问，他担任Number 2 Capital Corp.的总裁。他还是First TOors的联合创始人和董事，并且在First TOors交易之前一直是其首席执行官。Cooper先生自2003年起担任Reparo Energy Partners Corp.的董事兼首席执行官，自2020年起担任Set Earth Holdings Corp.的董事兼首席财务官，自2023年起担任Navco Pharmaceuticals Inc.的高级职员。Cooper先生目前担任以下上市公司的董事：Planet Ventures Inc.、Coled Ties Capital、Manning Ventures Inc.、Xcite Resces Inc.、Atco Mining Inc.、Starlo Ventures Ltd.、American Salars Lithium Inc.和Goldhaven Resces Corp.。他曾担任Bullion Gold Resces Corp.、StartMonday Technology Corp.、Anthem United Inc.、Aroway Energy Inc.、Edge Resces Inc.、Fion Gold Ltd.、Harry Manufacturing Inc.、Inform Resces Corp.、Leocor Ventures Inc.、Magnitude Mining Ltd.、Valens Groworks Corp.、Level 14 Ventures Ltd.、New Leaf Ventures Inc.、Savannah Minerals Corp.、Global Helium Corp和Spod Lithium Corp. Cooper先生还在2005年至2021年期间担任Counterpath Corporation（纳斯达克：CPAH）的董事，该公司是一家纳斯达克上市公司，于2021年3月被Alianza，Inc.以2560万美元收购。Cooper先生在2018年至2023年期间担任Alpha Lithium Corporation的董事，该公司于2023年10月被TecPetrol以约3.13亿加元的价格收购。此外，Cooper先生还获得了霍夫斯特拉大学的Biness Administration学士学位和纽约道林学院的Biness Administration硕士学位。
Christopher Cooper has served as one of directors since April 2024. Mr. Cooper has over 20 years of biness experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors. His experience includes spearheading growth strategies, financial reporting, quarterly and annual budgets, overseeing corporate administration, while achieving company objectives and maintaining internal cost controls. Mr. Cooper's current primary occupation is a biness consultant, and he serves as the president of Number 2 Capital Corp. He is also a co founder and director of First Tors and was its Chief Executive Officer until the First Tors Transaction. Mr. Cooper has been serving as a director and CEO of Reparo Energy Partners Corp. since 2003, a director and CFO of Set Earth Holdings Corp since 2020, and an officer of Navco Pharmaceuticals Inc. since 2023. Mr. Cooper presently serves as a director of the following publicly traded companies: Planet Ventures Inc., Coled Ties Capital, Manning Ventures Inc., Xcite Resces Inc., Atco Mining Inc., Starlo Ventures Ltd., American Salars Lithium Inc., and Goldhaven Resces Corp. He has previoly been a director of Bullion Gold Resces Corp., StartMonday Technology Corp., Anthem United Inc., Aroway Energy Inc., Edge Resces Inc., Fion Gold Ltd., Harry Manufacturing Inc., Inform Resces Corp., Leocor Ventures Inc., Magnitude Mining Ltd., Valens Groworks Corp., Level 14 Ventures Ltd., New Leaf Ventures Inc., Savannah Minerals Corp., Global Helium Corp., and Spod Lithium Corp. Mr. Cooper was also a director of Counterpath Corporation (Nasdaq: CPAH) from 2005 to 2021, a Nasdaq listed company which was acquired by Alianza, Inc. in March 2021 for D$25.6 million. Mr. Cooper was a director of Alpha Lithium Corporation from 2018 to 2023, which was acquired by Tecpetrol in October 2023 for approximately CAD$313 million. In addition, Mr. Cooper received his Bachelor of Biness Administration from Hofstra University and his Master's in Biness Administration from Dowling College in New York. - 克里斯托弗.库珀自2024年4月起担任董事之一。Cooper先生在私营和公共部门的企业发展、高级管理层、财务和运营的各个方面拥有超过20年的BINCE经验。他的经验包括领导增长战略、财务报告、季度和年度预算、监督公司管理，同时实现公司目标和保持内部成本控制。Cooper先生目前的主要职业是BINCE顾问，他担任Number 2 Capital Corp.的总裁。他还是First TOors的联合创始人和董事，并且在First TOors交易之前一直是其首席执行官。Cooper先生自2003年起担任Reparo Energy Partners Corp.的董事兼首席执行官，自2020年起担任Set Earth Holdings Corp.的董事兼首席财务官，自2023年起担任Navco Pharmaceuticals Inc.的高级职员。Cooper先生目前担任以下上市公司的董事：Planet Ventures Inc.、Coled Ties Capital、Manning Ventures Inc.、Xcite Resces Inc.、Atco Mining Inc.、Starlo Ventures Ltd.、American Salars Lithium Inc.和Goldhaven Resces Corp.。他曾担任Bullion Gold Resces Corp.、StartMonday Technology Corp.、Anthem United Inc.、Aroway Energy Inc.、Edge Resces Inc.、Fion Gold Ltd.、Harry Manufacturing Inc.、Inform Resces Corp.、Leocor Ventures Inc.、Magnitude Mining Ltd.、Valens Groworks Corp.、Level 14 Ventures Ltd.、New Leaf Ventures Inc.、Savannah Minerals Corp.、Global Helium Corp和Spod Lithium Corp. Cooper先生还在2005年至2021年期间担任Counterpath Corporation（纳斯达克：CPAH）的董事，该公司是一家纳斯达克上市公司，于2021年3月被Alianza，Inc.以2560万美元收购。Cooper先生在2018年至2023年期间担任Alpha Lithium Corporation的董事，该公司于2023年10月被TecPetrol以约3.13亿加元的价格收购。此外，Cooper先生还获得了霍夫斯特拉大学的Biness Administration学士学位和纽约道林学院的Biness Administration硕士学位。
- Christopher Cooper has served as one of directors since April 2024. Mr. Cooper has over 20 years of biness experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors. His experience includes spearheading growth strategies, financial reporting, quarterly and annual budgets, overseeing corporate administration, while achieving company objectives and maintaining internal cost controls. Mr. Cooper's current primary occupation is a biness consultant, and he serves as the president of Number 2 Capital Corp. He is also a co founder and director of First Tors and was its Chief Executive Officer until the First Tors Transaction. Mr. Cooper has been serving as a director and CEO of Reparo Energy Partners Corp. since 2003, a director and CFO of Set Earth Holdings Corp since 2020, and an officer of Navco Pharmaceuticals Inc. since 2023. Mr. Cooper presently serves as a director of the following publicly traded companies: Planet Ventures Inc., Coled Ties Capital, Manning Ventures Inc., Xcite Resces Inc., Atco Mining Inc., Starlo Ventures Ltd., American Salars Lithium Inc., and Goldhaven Resces Corp. He has previoly been a director of Bullion Gold Resces Corp., StartMonday Technology Corp., Anthem United Inc., Aroway Energy Inc., Edge Resces Inc., Fion Gold Ltd., Harry Manufacturing Inc., Inform Resces Corp., Leocor Ventures Inc., Magnitude Mining Ltd., Valens Groworks Corp., Level 14 Ventures Ltd., New Leaf Ventures Inc., Savannah Minerals Corp., Global Helium Corp., and Spod Lithium Corp. Mr. Cooper was also a director of Counterpath Corporation (Nasdaq: CPAH) from 2005 to 2021, a Nasdaq listed company which was acquired by Alianza, Inc. in March 2021 for D$25.6 million. Mr. Cooper was a director of Alpha Lithium Corporation from 2018 to 2023, which was acquired by Tecpetrol in October 2023 for approximately CAD$313 million. In addition, Mr. Cooper received his Bachelor of Biness Administration from Hofstra University and his Master's in Biness Administration from Dowling College in New York.
- David Jenkins
-
David Jenkins自2023年2月起担任董事之一以及审计委员会和薪酬委员会成员。Jenkins先生目前担任Binovi Technologies Corp.的董事，自2021年12月起担任该职位；Kiaro Holdings Corp.（TSXV：KO）的董事，自2022年8月起担任该职位，自2023年6月起担任Kiaro的实习首席执行官和首席财务官；Levitee Labs的董事，自2022年1月起担任该职位；Pont Protein Ltd.（TSXV：HULK）的董事，自2022年3月起担任该职位；Boundary Gold & Copper Mining Ltd.的董事，他自2020年7月起担任该职位；担任Montego Resces Inc.董事，自2020年1月起担任该职位；担任Quantum Battery Metals Corp.董事，自2020年1月起担任该职位。
David Jenkins has served as one of directors and as a member of Audit Committee and Compensation Committee since February 2023. Mr. Jenkins is currently a director at Binovi Technologies Corp., a position that he has held since December 2021; a director at Kiaro Holdings Corp. (TSXV: KO), a position that he has held since Augt 2022 and intern CEO and CFO of Kiaro since June 2023; a director at Levitee Labs, a position that he has held since January 2022; a director at Pont Protein Ltd. (TSXV: HULK), a position that he has held since March 2022; a director at Boundary Gold & Copper Mining Ltd., a position that he has held since July 2020; a director at Montego Resces Inc., a position that he has held since January 2020; and a director at Quantum Battery Metals Corp., a position that he has held since January 2020. - David Jenkins自2023年2月起担任董事之一以及审计委员会和薪酬委员会成员。Jenkins先生目前担任Binovi Technologies Corp.的董事，自2021年12月起担任该职位；Kiaro Holdings Corp.（TSXV：KO）的董事，自2022年8月起担任该职位，自2023年6月起担任Kiaro的实习首席执行官和首席财务官；Levitee Labs的董事，自2022年1月起担任该职位；Pont Protein Ltd.（TSXV：HULK）的董事，自2022年3月起担任该职位；Boundary Gold & Copper Mining Ltd.的董事，他自2020年7月起担任该职位；担任Montego Resces Inc.董事，自2020年1月起担任该职位；担任Quantum Battery Metals Corp.董事，自2020年1月起担任该职位。
- David Jenkins has served as one of directors and as a member of Audit Committee and Compensation Committee since February 2023. Mr. Jenkins is currently a director at Binovi Technologies Corp., a position that he has held since December 2021; a director at Kiaro Holdings Corp. (TSXV: KO), a position that he has held since Augt 2022 and intern CEO and CFO of Kiaro since June 2023; a director at Levitee Labs, a position that he has held since January 2022; a director at Pont Protein Ltd. (TSXV: HULK), a position that he has held since March 2022; a director at Boundary Gold & Copper Mining Ltd., a position that he has held since July 2020; a director at Montego Resces Inc., a position that he has held since January 2020; and a director at Quantum Battery Metals Corp., a position that he has held since January 2020.
- Jatinder Dhaliwal
-
Jatinder Dhaliwal自2022年7月起担任董事之一，并担任审计委员会、薪酬委员会以及提名和公司治理委员会成员。Dhaliwal先生是一名注册药剂师，拥有丰富的资本市场经验，曾担任多家上市大麻公司的首席执行官和董事。Dhaliwal先生目前担任Binovi Technologies Corp.的董事兼首席执行官和财务官，自2022年1月起担任该职位；自2023年8月起担任LQR Hoe Inc.的董事；自2024年7月起担任Virpax Pharmaceutical Inc.的董事；自2022年8月至2023年5月担任Kiaro Holdings Corp.的董事兼首席执行官；曾担任Makara Mining Corp.的董事，他于2021年8月至2022年3月担任的职务；Global Health Clinics Ltd.的董事兼首席执行官，自2019年3月起担任该职务；EGF Theramed Health Corp.的董事兼首席执行官，自2022年1月至2022年8月担任该职务；Ravenquest Biomed Inc的董事，自2019年11月起担任该职务；Intact Gold Corp.的董事，自2019年11月至2020年6月担任该职务。Dhaliwal先生拥有不列颠哥伦比亚大学药学学士学位和维多利亚大学生物学理学学士学位。
Jatinder Dhaliwal has served as one of directors and as a member of Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee since July 2022. Mr. Dhaliwal is a registered pharmacist and has significant capital markets experience, having served as CEO and director of multiple publicly traded cannabis companies. Mr. Dhaliwal is currently a director and Chief Executive and Financial Officer at Binovi Technologies Corp., a position that he has held since January 2022; a director at LQR Hoe Inc., a position that he has held since Augt 2023; a director at Virpax Pharmaceutical Inc, a position that he has held since July 2024; was a director and Chief Executive at Kiaro Holdings Corp., a position that he held from Augt 2022 to May 2023; was a director at Makara Mining Corp., a position that he held from Augt 2021 to March 2022; a director and CEO at Global Health Clinics Ltd., a position that he has held since March 2019; a director and CEO at EGF Theramed Health Corp., a position that he held from January 2022 to Augt 2022; a director at Ravenquest Biomed Inc, a position that he has held since November 2019; and a director at Intact Gold Corp., a position that he held from November 2019 to June 2020. Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in Biology from the University of Victoria. - Jatinder Dhaliwal自2022年7月起担任董事之一，并担任审计委员会、薪酬委员会以及提名和公司治理委员会成员。Dhaliwal先生是一名注册药剂师，拥有丰富的资本市场经验，曾担任多家上市大麻公司的首席执行官和董事。Dhaliwal先生目前担任Binovi Technologies Corp.的董事兼首席执行官和财务官，自2022年1月起担任该职位；自2023年8月起担任LQR Hoe Inc.的董事；自2024年7月起担任Virpax Pharmaceutical Inc.的董事；自2022年8月至2023年5月担任Kiaro Holdings Corp.的董事兼首席执行官；曾担任Makara Mining Corp.的董事，他于2021年8月至2022年3月担任的职务；Global Health Clinics Ltd.的董事兼首席执行官，自2019年3月起担任该职务；EGF Theramed Health Corp.的董事兼首席执行官，自2022年1月至2022年8月担任该职务；Ravenquest Biomed Inc的董事，自2019年11月起担任该职务；Intact Gold Corp.的董事，自2019年11月至2020年6月担任该职务。Dhaliwal先生拥有不列颠哥伦比亚大学药学学士学位和维多利亚大学生物学理学学士学位。
- Jatinder Dhaliwal has served as one of directors and as a member of Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee since July 2022. Mr. Dhaliwal is a registered pharmacist and has significant capital markets experience, having served as CEO and director of multiple publicly traded cannabis companies. Mr. Dhaliwal is currently a director and Chief Executive and Financial Officer at Binovi Technologies Corp., a position that he has held since January 2022; a director at LQR Hoe Inc., a position that he has held since Augt 2023; a director at Virpax Pharmaceutical Inc, a position that he has held since July 2024; was a director and Chief Executive at Kiaro Holdings Corp., a position that he held from Augt 2022 to May 2023; was a director at Makara Mining Corp., a position that he held from Augt 2021 to March 2022; a director and CEO at Global Health Clinics Ltd., a position that he has held since March 2019; a director and CEO at EGF Theramed Health Corp., a position that he held from January 2022 to Augt 2022; a director at Ravenquest Biomed Inc, a position that he has held since November 2019; and a director at Intact Gold Corp., a position that he held from November 2019 to June 2020. Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in Biology from the University of Victoria.
高管简历
中英对照 | 中文 | 英文- Katharyn Field
Katharyn Field，自2024年10月起担任Logprostyle Inc.独立董事。在为Logprostyle Inc.公司服务期间，Field女士还曾在Virpax Pharmaceuticals Inc.担任独立董事和审计委员会成员，该公司是一家专业制药公司，专注于凭借其旗舰产品利用专有脂质体封装（纳斯达克：VRPX）开创先进的医疗保健解决方案，自2024年7月起，在iSpecimen Inc.担任独立董事和审计委员会成员。TERM4 Inc.是一家提供技术的公司，该公司将需要人类生物流体、组织和活细胞进行研究的生命科学研究人员与全球医疗保健提供机构（TERM0纳斯达克：ISPC）中可用的生物标本连接起来，自2024年9月以来，自2022年7月起在Halo Collective Inc.担任首席执行官和董事会主席，该公司是一家在加拿大和美国从事大麻和大麻提取物的种植、制造、运输和分销的公司（OTC：HCANF），自2022年6月起在Akanda Corporation担任临时首席执行官和执行董事，该公司是一家为药用Logprostyle Inc. e worldwide（纳斯达克：AKAN）从事大麻制品种植、制造和分销的公司。在加入Logprostyle Inc.公司之前，Field女士曾于2013年1月至2017年1月在美国园艺种植商Costa Farms担任董事，于2017年1月至2018年1月担任顾问，于2018年1月至2019年3月在MariMed Inc.担任高级副总裁，该公司在美国和国际上从事药用和娱乐大麻的种植、生产和分配（OTC：MRMD），并于2019年4月至2020年2月担任Halo Collective Inc.的首席战略官，并于2020年2月至2022年7月担任其总裁。Field女士于2005年获得斯坦福大学公共政策学士学位，并于2011年获得哥伦比亚大学工商管理硕士学位。
Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field’s resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison’s office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University.- Katharyn Field，自2024年10月起担任Logprostyle Inc.独立董事。在为Logprostyle Inc.公司服务期间，Field女士还曾在Virpax Pharmaceuticals Inc.担任独立董事和审计委员会成员，该公司是一家专业制药公司，专注于凭借其旗舰产品利用专有脂质体封装（纳斯达克：VRPX）开创先进的医疗保健解决方案，自2024年7月起，在iSpecimen Inc.担任独立董事和审计委员会成员。TERM4 Inc.是一家提供技术的公司，该公司将需要人类生物流体、组织和活细胞进行研究的生命科学研究人员与全球医疗保健提供机构（TERM0纳斯达克：ISPC）中可用的生物标本连接起来，自2024年9月以来，自2022年7月起在Halo Collective Inc.担任首席执行官和董事会主席，该公司是一家在加拿大和美国从事大麻和大麻提取物的种植、制造、运输和分销的公司（OTC：HCANF），自2022年6月起在Akanda Corporation担任临时首席执行官和执行董事，该公司是一家为药用Logprostyle Inc. e worldwide（纳斯达克：AKAN）从事大麻制品种植、制造和分销的公司。在加入Logprostyle Inc.公司之前，Field女士曾于2013年1月至2017年1月在美国园艺种植商Costa Farms担任董事，于2017年1月至2018年1月担任顾问，于2018年1月至2019年3月在MariMed Inc.担任高级副总裁，该公司在美国和国际上从事药用和娱乐大麻的种植、生产和分配（OTC：MRMD），并于2019年4月至2020年2月担任Halo Collective Inc.的首席战略官，并于2020年2月至2022年7月担任其总裁。Field女士于2005年获得斯坦福大学公共政策学士学位，并于2011年获得哥伦比亚大学工商管理硕士学位。
- Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field’s resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison’s office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University.
- Katharyn Field
Katharyn Field自2022年7月起担任执行董事，自2023年2月起担任临时首席执行官。菲尔德女士目前也是Halo的首席执行官兼董事长，她自2022年6月以来一直担任该职位。Field女士目前是LogProstyle的董事，自2025年2月起担任iSpecimen公司的总裁，这两家公司都是上市公司。从2020年2月到2022年6月，菲尔德女士担任大麻公司Halo Collective Inc.的总裁，从2019年4月到2020年2月，她担任该公司的首席战略官。菲尔德女士的履历包括2005年10月至2009年5月在布鲁金斯学会任职，2011年9月至2013年3月在贝恩公司任职。2014年，她进入大麻产业，领导了佛罗里达州五家拥有州许可证的原始垂直整合公司之一的采购、建设和销售。随后，Field女士经营着一家专注于大麻的战略咨询业务，并于2018年5月至2019年1月在MariMed工作，担任企业发展执行副总裁。菲尔德女士还在George W. BH执政期间完成了在白锄公共联络办公室的实习。菲尔德女士拥有哥伦比亚BINCE学校的MBA学位和斯坦福大学的荣誉学士学位。
Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field's resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison's office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University.- Katharyn Field自2022年7月起担任执行董事，自2023年2月起担任临时首席执行官。菲尔德女士目前也是Halo的首席执行官兼董事长，她自2022年6月以来一直担任该职位。Field女士目前是LogProstyle的董事，自2025年2月起担任iSpecimen公司的总裁，这两家公司都是上市公司。从2020年2月到2022年6月，菲尔德女士担任大麻公司Halo Collective Inc.的总裁，从2019年4月到2020年2月，她担任该公司的首席战略官。菲尔德女士的履历包括2005年10月至2009年5月在布鲁金斯学会任职，2011年9月至2013年3月在贝恩公司任职。2014年，她进入大麻产业，领导了佛罗里达州五家拥有州许可证的原始垂直整合公司之一的采购、建设和销售。随后，Field女士经营着一家专注于大麻的战略咨询业务，并于2018年5月至2019年1月在MariMed工作，担任企业发展执行副总裁。菲尔德女士还在George W. BH执政期间完成了在白锄公共联络办公室的实习。菲尔德女士拥有哥伦比亚BINCE学校的MBA学位和斯坦福大学的荣誉学士学位。
- Katharyn Field has served as Executive Director since July 2022 and Interim Chief Executive Officer since February 2023. Ms. Field is also currently CEO and Chairman of Halo, a position she has held since June 2022. Ms. Field is currently a director of LogProstyle and since February 2025 has been President of iSpecimen Inc., which are both publicly traded companies. From February 2020 to June 2022, Ms. Field served as the president of Halo Collective Inc., a cannabis company, and from April 2019 through February 2020, she served as its Chief Strategy Officer. Ms. Field's resume includes positions at the Brookings Institution, from October 2005 to May 2009 and Bain & Company from September 2011 to March 2013. In 2014, she entered the cannabis indtry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice foced on cannabis and also worked at MariMed from May 2018 to January 2019 as Executive Vice President of Corporate Development. Ms. Field also completed an internship in the public liaison's office of The White Hoe during the George W. Bh administration. Ms. Field holds an MBA from Columbia Biness School and a BA with honors from Stanford University.
- Gurcharn Deol
Gurcharn Deol自2023年12月4日起担任首席财务官。Deol先生是一位多行业高管，拥有超过35年的上市公司管理经验。Deol先生目前担任Green Battery Metals Corp、Trilogy AI Corp和Bayridge Resces Corp.的董事，这些公司都是在加拿大证券交易所交易的上市公司。Deol先生最近的经历包括担任加拿大numero私营和上市公司的董事或管理层，包括Bayridge Resces Inc.的首席执行官、Trilogy AI Corp（Ambari Brands Inc.的新名称）、Green Battery Minerals Inc.、Argyle Resces Corp和Neotech Metals Inc.的董事。他参与了正在成立的首次IPO，这需要通过上市的监管程序让加拿大的私营公司。Deol先生拥有生理和咨询心理学学士、硕士、博士学位。
Gurcharn Deol has served as Chief Financial Officer since December 4, 2023. Mr. Deol is a multi indtry executive with over 35 years of public company management experience. Mr Deol is currently a director of Green Battery Metals Corp, Trilogy AI Corp and Bayridge Resces Corp., which are all public companies trading on the Canadian Stock Exchanges. Mr. Deol’s recent experiences include being a director or in management of numero Canadian private and public companies including CEO of Bayridge Resces Inc., a director of Trilogy AI Corp (new name for Ambari Brands Inc.), Green Battery Minerals Inc., Argyle Resces Corp and Neotech Metals Inc. He has been involved in initial IPOs being established which required taking private companies in Canada through the regulatory process of going public. Mr. Deol holds a B.A., M.A., PhD in Physiological and Counseling Psychology.- Gurcharn Deol自2023年12月4日起担任首席财务官。Deol先生是一位多行业高管，拥有超过35年的上市公司管理经验。Deol先生目前担任Green Battery Metals Corp、Trilogy AI Corp和Bayridge Resces Corp.的董事，这些公司都是在加拿大证券交易所交易的上市公司。Deol先生最近的经历包括担任加拿大numero私营和上市公司的董事或管理层，包括Bayridge Resces Inc.的首席执行官、Trilogy AI Corp（Ambari Brands Inc.的新名称）、Green Battery Minerals Inc.、Argyle Resces Corp和Neotech Metals Inc.的董事。他参与了正在成立的首次IPO，这需要通过上市的监管程序让加拿大的私营公司。Deol先生拥有生理和咨询心理学学士、硕士、博士学位。
- Gurcharn Deol has served as Chief Financial Officer since December 4, 2023. Mr. Deol is a multi indtry executive with over 35 years of public company management experience. Mr Deol is currently a director of Green Battery Metals Corp, Trilogy AI Corp and Bayridge Resces Corp., which are all public companies trading on the Canadian Stock Exchanges. Mr. Deol’s recent experiences include being a director or in management of numero Canadian private and public companies including CEO of Bayridge Resces Inc., a director of Trilogy AI Corp (new name for Ambari Brands Inc.), Green Battery Minerals Inc., Argyle Resces Corp and Neotech Metals Inc. He has been involved in initial IPOs being established which required taking private companies in Canada through the regulatory process of going public. Mr. Deol holds a B.A., M.A., PhD in Physiological and Counseling Psychology.
- Edgar Contreras
Edgar Contreras拥有30年的公司律师经验，自2002年起专门从事电信行业。他被视为谈判购买战略电信站点、资金流动、收入的专家。Contreras先生曾与领先的公司合作，如美国的Tor和诺基亚，处理运营事务，并担任墨西哥APWireless的运营总监，APWireless是世界上在电信网站上购买资金流的领先企业。他的丰富经验包括在墨西哥建造了1000多个防弹少年团站点，以及5000多个电信选址地点的谈判租赁。Contreras previoly先生拥有并经营Nextel de Mexico，该公司仅在3个月内就完成了100项物业租赁以安装电信基础设施。Contreras previoly先生在成为First Tors的国家经理之前管理过First Tors的光纤业务。
Edgar Contreras has 30 years of experience as a corporate lawyer, specializing in the telecommunication indtry since 2002. He is regarded as an expert in negotiating the purchase of strategic telecommunication sites, money flow, and income. Mr. Contreras has worked with leading companies, such as American Tor and Nokia, on operational matters and serves as operations director for Mexico’s APWireless, a leader in the world for the purchase of money flow on telecommunication sites. His extensive experience has included the construction of more than 1,000 BTS sites in Mexico and over 5,000 negotiations rentals of telecommunication siting locations. Mr. Contreras previoly owned and operated Nextel de Mexico, which accomplished 100 property leases to install telecommunications infrastructure in only 3 months. Mr. Contreras previoly managed First Tors’ fiber optic biness prior to becoming its National Manager.- Edgar Contreras拥有30年的公司律师经验，自2002年起专门从事电信行业。他被视为谈判购买战略电信站点、资金流动、收入的专家。Contreras先生曾与领先的公司合作，如美国的Tor和诺基亚，处理运营事务，并担任墨西哥APWireless的运营总监，APWireless是世界上在电信网站上购买资金流的领先企业。他的丰富经验包括在墨西哥建造了1000多个防弹少年团站点，以及5000多个电信选址地点的谈判租赁。Contreras previoly先生拥有并经营Nextel de Mexico，该公司仅在3个月内就完成了100项物业租赁以安装电信基础设施。Contreras previoly先生在成为First Tors的国家经理之前管理过First Tors的光纤业务。
- Edgar Contreras has 30 years of experience as a corporate lawyer, specializing in the telecommunication indtry since 2002. He is regarded as an expert in negotiating the purchase of strategic telecommunication sites, money flow, and income. Mr. Contreras has worked with leading companies, such as American Tor and Nokia, on operational matters and serves as operations director for Mexico’s APWireless, a leader in the world for the purchase of money flow on telecommunication sites. His extensive experience has included the construction of more than 1,000 BTS sites in Mexico and over 5,000 negotiations rentals of telecommunication siting locations. Mr. Contreras previoly owned and operated Nextel de Mexico, which accomplished 100 property leases to install telecommunications infrastructure in only 3 months. Mr. Contreras previoly managed First Tors’ fiber optic biness prior to becoming its National Manager.
- Christopher Cooper
克里斯托弗.库珀自2024年4月起担任董事之一。Cooper先生在私营和公共部门的企业发展、高级管理层、财务和运营的各个方面拥有超过20年的BINCE经验。他的经验包括领导增长战略、财务报告、季度和年度预算、监督公司管理，同时实现公司目标和保持内部成本控制。Cooper先生目前的主要职业是BINCE顾问，他担任Number 2 Capital Corp.的总裁。他还是First TOors的联合创始人和董事，并且在First TOors交易之前一直是其首席执行官。Cooper先生自2003年起担任Reparo Energy Partners Corp.的董事兼首席执行官，自2020年起担任Set Earth Holdings Corp.的董事兼首席财务官，自2023年起担任Navco Pharmaceuticals Inc.的高级职员。Cooper先生目前担任以下上市公司的董事：Planet Ventures Inc.、Coled Ties Capital、Manning Ventures Inc.、Xcite Resces Inc.、Atco Mining Inc.、Starlo Ventures Ltd.、American Salars Lithium Inc.和Goldhaven Resces Corp.。他曾担任Bullion Gold Resces Corp.、StartMonday Technology Corp.、Anthem United Inc.、Aroway Energy Inc.、Edge Resces Inc.、Fion Gold Ltd.、Harry Manufacturing Inc.、Inform Resces Corp.、Leocor Ventures Inc.、Magnitude Mining Ltd.、Valens Groworks Corp.、Level 14 Ventures Ltd.、New Leaf Ventures Inc.、Savannah Minerals Corp.、Global Helium Corp和Spod Lithium Corp. Cooper先生还在2005年至2021年期间担任Counterpath Corporation（纳斯达克：CPAH）的董事，该公司是一家纳斯达克上市公司，于2021年3月被Alianza，Inc.以2560万美元收购。Cooper先生在2018年至2023年期间担任Alpha Lithium Corporation的董事，该公司于2023年10月被TecPetrol以约3.13亿加元的价格收购。此外，Cooper先生还获得了霍夫斯特拉大学的Biness Administration学士学位和纽约道林学院的Biness Administration硕士学位。
Christopher Cooper has served as one of directors since April 2024. Mr. Cooper has over 20 years of biness experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors. His experience includes spearheading growth strategies, financial reporting, quarterly and annual budgets, overseeing corporate administration, while achieving company objectives and maintaining internal cost controls. Mr. Cooper's current primary occupation is a biness consultant, and he serves as the president of Number 2 Capital Corp. He is also a co founder and director of First Tors and was its Chief Executive Officer until the First Tors Transaction. Mr. Cooper has been serving as a director and CEO of Reparo Energy Partners Corp. since 2003, a director and CFO of Set Earth Holdings Corp since 2020, and an officer of Navco Pharmaceuticals Inc. since 2023. Mr. Cooper presently serves as a director of the following publicly traded companies: Planet Ventures Inc., Coled Ties Capital, Manning Ventures Inc., Xcite Resces Inc., Atco Mining Inc., Starlo Ventures Ltd., American Salars Lithium Inc., and Goldhaven Resces Corp. He has previoly been a director of Bullion Gold Resces Corp., StartMonday Technology Corp., Anthem United Inc., Aroway Energy Inc., Edge Resces Inc., Fion Gold Ltd., Harry Manufacturing Inc., Inform Resces Corp., Leocor Ventures Inc., Magnitude Mining Ltd., Valens Groworks Corp., Level 14 Ventures Ltd., New Leaf Ventures Inc., Savannah Minerals Corp., Global Helium Corp., and Spod Lithium Corp. Mr. Cooper was also a director of Counterpath Corporation (Nasdaq: CPAH) from 2005 to 2021, a Nasdaq listed company which was acquired by Alianza, Inc. in March 2021 for D$25.6 million. Mr. Cooper was a director of Alpha Lithium Corporation from 2018 to 2023, which was acquired by Tecpetrol in October 2023 for approximately CAD$313 million. In addition, Mr. Cooper received his Bachelor of Biness Administration from Hofstra University and his Master's in Biness Administration from Dowling College in New York.- 克里斯托弗.库珀自2024年4月起担任董事之一。Cooper先生在私营和公共部门的企业发展、高级管理层、财务和运营的各个方面拥有超过20年的BINCE经验。他的经验包括领导增长战略、财务报告、季度和年度预算、监督公司管理，同时实现公司目标和保持内部成本控制。Cooper先生目前的主要职业是BINCE顾问，他担任Number 2 Capital Corp.的总裁。他还是First TOors的联合创始人和董事，并且在First TOors交易之前一直是其首席执行官。Cooper先生自2003年起担任Reparo Energy Partners Corp.的董事兼首席执行官，自2020年起担任Set Earth Holdings Corp.的董事兼首席财务官，自2023年起担任Navco Pharmaceuticals Inc.的高级职员。Cooper先生目前担任以下上市公司的董事：Planet Ventures Inc.、Coled Ties Capital、Manning Ventures Inc.、Xcite Resces Inc.、Atco Mining Inc.、Starlo Ventures Ltd.、American Salars Lithium Inc.和Goldhaven Resces Corp.。他曾担任Bullion Gold Resces Corp.、StartMonday Technology Corp.、Anthem United Inc.、Aroway Energy Inc.、Edge Resces Inc.、Fion Gold Ltd.、Harry Manufacturing Inc.、Inform Resces Corp.、Leocor Ventures Inc.、Magnitude Mining Ltd.、Valens Groworks Corp.、Level 14 Ventures Ltd.、New Leaf Ventures Inc.、Savannah Minerals Corp.、Global Helium Corp和Spod Lithium Corp. Cooper先生还在2005年至2021年期间担任Counterpath Corporation（纳斯达克：CPAH）的董事，该公司是一家纳斯达克上市公司，于2021年3月被Alianza，Inc.以2560万美元收购。Cooper先生在2018年至2023年期间担任Alpha Lithium Corporation的董事，该公司于2023年10月被TecPetrol以约3.13亿加元的价格收购。此外，Cooper先生还获得了霍夫斯特拉大学的Biness Administration学士学位和纽约道林学院的Biness Administration硕士学位。
- Christopher Cooper has served as one of directors since April 2024. Mr. Cooper has over 20 years of biness experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors. His experience includes spearheading growth strategies, financial reporting, quarterly and annual budgets, overseeing corporate administration, while achieving company objectives and maintaining internal cost controls. Mr. Cooper's current primary occupation is a biness consultant, and he serves as the president of Number 2 Capital Corp. He is also a co founder and director of First Tors and was its Chief Executive Officer until the First Tors Transaction. Mr. Cooper has been serving as a director and CEO of Reparo Energy Partners Corp. since 2003, a director and CFO of Set Earth Holdings Corp since 2020, and an officer of Navco Pharmaceuticals Inc. since 2023. Mr. Cooper presently serves as a director of the following publicly traded companies: Planet Ventures Inc., Coled Ties Capital, Manning Ventures Inc., Xcite Resces Inc., Atco Mining Inc., Starlo Ventures Ltd., American Salars Lithium Inc., and Goldhaven Resces Corp. He has previoly been a director of Bullion Gold Resces Corp., StartMonday Technology Corp., Anthem United Inc., Aroway Energy Inc., Edge Resces Inc., Fion Gold Ltd., Harry Manufacturing Inc., Inform Resces Corp., Leocor Ventures Inc., Magnitude Mining Ltd., Valens Groworks Corp., Level 14 Ventures Ltd., New Leaf Ventures Inc., Savannah Minerals Corp., Global Helium Corp., and Spod Lithium Corp. Mr. Cooper was also a director of Counterpath Corporation (Nasdaq: CPAH) from 2005 to 2021, a Nasdaq listed company which was acquired by Alianza, Inc. in March 2021 for D$25.6 million. Mr. Cooper was a director of Alpha Lithium Corporation from 2018 to 2023, which was acquired by Tecpetrol in October 2023 for approximately CAD$313 million. In addition, Mr. Cooper received his Bachelor of Biness Administration from Hofstra University and his Master's in Biness Administration from Dowling College in New York.
- Francisco Juarez
Francisco Juarez是First Tors的联合创始人，自2018年起担任首席运营官和董事。自2008年起，他还担任IGS Corp.的董事和创始人。他带来了超过15年的经验，为公司创建biness模型，从而成为客户的最佳biness合作伙伴。
Francisco Juarez is a co founder of First Tors and its Chief Operating Officer and a director since 2018. He is also a director and founder of IGS Corp. since 2008. He has over 15 years of experience creating biness models for companies to become the best biness partner for their clientele.- Francisco Juarez是First Tors的联合创始人，自2018年起担任首席运营官和董事。自2008年起，他还担任IGS Corp.的董事和创始人。他带来了超过15年的经验，为公司创建biness模型，从而成为客户的最佳biness合作伙伴。
- Francisco Juarez is a co founder of First Tors and its Chief Operating Officer and a director since 2018. He is also a director and founder of IGS Corp. since 2008. He has over 15 years of experience creating biness models for companies to become the best biness partner for their clientele.